tiprankstipranks
Trending News
More News >
Elevance Health (ELV)
NYSE:ELV
US Market
Advertisement

Elevance Health (ELV) Earnings Dates, Call Summary & Reports

Compare
2,855 Followers

Earnings Data

Report Date
Jan 28, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
3.19
Last Year’s EPS
3.84
Same Quarter Last Year
Based on 14 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Oct 21, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call reflected a mixed outlook with strong revenue growth and strategic advancements in AI and Carelon, but faced challenges in Medicaid margins and potential impacts from subsidy expirations in the ACA market.
Company Guidance
During the Elevance Health Third Quarter Earnings Conference Call, the company reaffirmed its 2025 adjusted earnings per share (EPS) guidance of approximately $30, with a baseline EPS of $27 excluding $3 of discrete nonrecurring items. The call highlighted a 12% year-over-year increase in total operating revenue to $50.1 billion, driven by higher premium yields, recent acquisitions, and growth in Medicare Advantage membership. The benefit expense ratio was in line with expectations at 91.3%. The company anticipates a year-over-year decline of at least 125 basis points in Medicaid margins for 2026 due to elevated acuity and utilization trends. Elevance Health also noted strong external revenue growth in its Carelon segment and emphasized strategic investments in technology and value-based care to enhance long-term performance. The company plans to provide a more detailed 2026 outlook in January, considering factors such as Medicaid rate updates, Medicare AEP outcomes, and the status of enhanced ACA subsidies.
Revenue Growth and Medicare Advantage Performance
Elevance Health reported total operating revenue of $50.1 billion, up 12% year-over-year, driven by higher premium yields, recently closed acquisitions, and Medicare Advantage membership growth.
Carelon's Strong Momentum
Carelon exhibited strong performance with Carelon Rx revenue growing 20% year-over-year and Carelon Services growing by more than 50%, reflecting robust organic growth and integration efforts.
AI and Technology Investments
Investments in AI and technology are expected to drive efficiency, improve affordability, and enhance member and provider experiences across the Elevance Health platform.
Stable Medicare Advantage Margins
Medicare Advantage costs were marginally better than expected, with a potential for slight improvement in operating margin for 2025, supported by disciplined plan design and member composition.
Improved Star Ratings
For the 2027 payment year, approximately 55% of MA members will be in 4-star or higher contracts, including three 5-star contracts, up from about 40% for payment year 2026.

Elevance Health (ELV) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ELV Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jan 28, 2026
2025 (Q4)
3.19 / -
3.84
Oct 21, 2025
2025 (Q3)
4.93 / 6.03
8.37-27.96% (-2.34)
Jul 17, 2025
2025 (Q2)
8.91 / 8.84
10.12-12.65% (-1.28)
Apr 22, 2025
2025 (Q1)
11.41 / 11.97
10.6412.50% (+1.33)
Jan 23, 2025
2024 (Q4)
4.01 / 3.84
5.62-31.67% (-1.78)
Oct 17, 2024
2024 (Q3)
9.66 / 8.37
8.99-6.90% (-0.62)
Jul 17, 2024
2024 (Q2)
10.00 / 10.12
9.0411.95% (+1.08)
Apr 18, 2024
2024 (Q1)
10.52 / 10.64
9.4612.47% (+1.18)
Jan 24, 2024
2023 (Q4)
5.60 / 5.62
5.237.46% (+0.39)
Oct 18, 2023
2023 (Q3)
8.46 / 8.99
7.5319.39% (+1.46)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ELV Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 21, 2025
$354.07$349.75-1.22%
Jul 17, 2025
$342.68$300.81-12.22%
Apr 22, 2025
$402.71$411.83+2.26%
Jan 23, 2025
$385.29$395.77+2.72%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Elevance Health (ELV) report earnings?
Elevance Health (ELV) is schdueled to report earning on Jan 28, 2026, Before Open (Confirmed).
    What is Elevance Health (ELV) earnings time?
    Elevance Health (ELV) earnings time is at Jan 28, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ELV EPS forecast?
          ELV EPS forecast for the fiscal quarter 2025 (Q4) is 3.19.

            Elevance Health (ELV) Earnings News

            ELV Earnings: Elevance Reports Better-than-Expected Q2 Results
            Premium
            Market News
            ELV Earnings: Elevance Reports Better-than-Expected Q2 Results
            1y ago
            Elevance Health (NYSE:ELV) Jumps after Exceeding Q4 Estimates
            Premium
            Market News
            Elevance Health (NYSE:ELV) Jumps after Exceeding Q4 Estimates
            2y ago
            Elevance (NYSE:ELV) Pops on Q2 Beat; Guidance Impresses
            Premium
            Market News
            Elevance (NYSE:ELV) Pops on Q2 Beat; Guidance Impresses
            2y ago
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis